Assetmark Inc. increased its holdings in SpringWorks Therapeutics, Inc. () by 82.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.

Source: https://www.etfdailynews.com/2023/01/22/assetmark-inc-acquires-1494-shares-of-springworks-therapeutics-inc-nasdaqswtx/

Finally, Vanguard Group Inc. lifted its holdings in shares of SpringWorks Therapeutics by 0.7% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/07/23/julie-hambleton-sells-2418-shares-of-springworks-therapeutics-inc-nasdaqswtx-stock/

FMR LLC boosted its position in shares of SpringWorks Therapeutics by 22.6% during the 2nd quarter.

Source: https://www.etfdailynews.com/2023/01/30/barclays-plc-buys-139337-shares-of-springworks-therapeutics-inc-nasdaqswtx/

Nomura Holdings Inc. acquired a new stake in shares of SpringWorks Therapeutics in the second quarter worth $13,432,000.

Source: https://www.etfdailynews.com/2023/01/21/cwm-llc-has-36000-stock-holdings-in-springworks-therapeutics-inc-nasdaqswtx/

State Street Corp increased its holdings in shares of SpringWorks Therapeutics by 143.7% in the 2nd quarter.

Source: https://www.etfdailynews.com/2023/06/07/brokers-issue-forecasts-for-springworks-therapeutics-inc-s-fy2023-earnings-nasdaqswtx/

The Goldman Sachs Group increased their target price on SpringWorks Therapeutics from $43.00 to $49.00 and gave the stock a “buy” rating in a report on Thursday, July 20th.

Source: https://www.etfdailynews.com/2023/08/14/assetmark-inc-has-149000-position-in-springworks-therapeutics-inc-nasdaqswtx/